Human receives AI-designed virus for the first time

A first test in a person

Radical Numerics, a San Francisco AI lab, says it treated one patient with a cocktail (a mix) of viruses it designed with its AI model, Omnii-1. The viruses are called bacteriophages, or phages for short. They attack bacteria, not human cells. The treatment was given under a compassionate-use arrangement, which lets patients try a treatment that is not yet approved when other options have failed. The company has not said how the patient did.

Key facts

• The treatment was given to one patient.
• In lab tests, the cocktail wiped out the patient's antibiotic-resistant bacteria in a dish (in vitro).
• The company has not shared any results from the patient.
• It has not said what infection the patient had.
• Omnii-1 was publicly unveiled the same week as the announcement.

Why viruses that eat bacteria?

Some bacteria now resist antibiotics, so the medicines often stop working. Phages are seen as one option. They can target specific types of bacteria. Broad antibiotics can also kill helpful gut bacteria, but phages may spare them. Last year, researchers at Stanford University and the Arc Institute used AI to design phages that attack E. coli bacteria, and some versions worked better than the natural virus they were based on.

Why it matters

This shows AI can help move phage design from computer predictions to real patients. But one patient proves very little. The company itself warns that its results do not show the therapy is safe or works. Doctors and scientists will need much more testing before anyone can say AI-made phages are a reliable treatment.

What to watch

• Whether Radical Numerics shares results from the patient.
• What infection the patient had and whether the treatment helped.
• Whether the company runs larger, formal clinical trials.
• How well Omnii-1 predicts which phages can infect Pseudomonas aeruginosa, a bacterium that can cause wound and lung infections.